ArticleScientific reports2018

The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson's disease.

Diana L Price et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.